Biotech

Thermo Fisher Q4 revenue, earnings beat estimates; stock drops on weak guidance

January 29, 2026

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

September 27, 2022

Biogen posts Q3 earnings well above estimates

October 20, 2021

Gilead Sciences, Inc (GILD): Q3 2019 Earnings Snapshot

October 24, 2019

Alexion Pharmaceuticals, (ALXN): Q3 2019 Earnings Snapshot

October 23, 2019

Thermo Fisher Scientific (TMO): Q3 2019 Earnings Snapshot

October 23, 2019

Biogen (BIIB) Q3 profit rises 7% on spinal muscular atrophy drug addition

October 22, 2019

4 biotech stocks that are ideal takeover targets

August 28, 2019

Bio-Path’s loss expands in Q2

August 15, 2019

Earnings preview: Will losses continue for Celsion in Q2

August 13, 2019

Progenics posts wider-than-expected loss in Q2

August 9, 2019

What to look for when Progenics Pharma posts Q2 earnings

August 7, 2019

Is Advaxis exhausting its financial resources with the stock hitting a record low?

July 9, 2019

Cara Therapeutics Q1 loss widens but beats estimates

May 7, 2019

ImmunoGen is cheap ahead of Q1 earnings, but is it worth?

May 2, 2019

Biocept narrows loss in Q4

March 28, 2019

Earnings preview: What’s on the cards for Biocept in Q4

March 27, 2019

Earnings: Affimed cuts down losses in 2018

March 27, 2019

Onconova Therapeutics cuts down losses in 2018

March 26, 2019

Earnings Preview: Aeterna Zentaris reporting Q4 results on Mar 26

March 24, 2019

What is NASH and which biotech firms are vying for the first-mover status

March 20, 2019